Výsledky vyhledávání - "O I Sagalova"

Akademický článek

Chronic hepatitis C in Russia: current challenges and prospects

Autor: V P Chulanov, N N Pimenov, N A Mamonova, O I Sagalova, I V Shestakova, V I Pokrovsky

Publikováno v: Терапевтический архив, Vol 87, Iss 11, Pp 5-10 (2015)

This paper evaluates the impact of different medical care strategies for chronic hepatitis C patients in relation to its prevalence, frequency of adverse outcomes and mortality rate.

Externí odkaz: https://doaj.org/article/9a328faa777d4f9299c729d1451e75f7

Zobrazit plný text záznamu

Akademický článek

Norovirus infection in general hospitals for adults

Autor: O I Sagalova, I V Bryzgalova, A T Podkolzin, V V Maleev

Publikováno v: Терапевтический архив, Vol 81, Iss 4, Pp 60-63 (2009)

Aim. To determine the role of noroviruses in the rise of hospital outbreaks of acute intestinal infections (AII), to study clinical and epidemiological aspects of hospital noroviral infection. Material and methods. Routine diagnostic methods and diag

Externí odkaz: https://doaj.org/article/b70e06c4555f41eba17a64188f4225dd

Zobrazit plný text záznamu

Modes of antiviral therapy containing daclatasvir, when mixed cryoglobulinemia associated with chronic infection with hepatitis C virus (multicentre study in the framework of individual access)

Autor: D.T. Abdurakhmanov, Igor G. Bakulin, V.I. Chervinko, M. B. Mayevskaya, S. N. Kizhlo, Mikhail L. Zubkin, O. I. Sagalova, Irina Kim, Vladimir Ivashkin

Publikováno v: Clinical Medicine (Russian Journal). 96:820-825

Mixed cryoglobulinemia (MC) and cryoglobulinemic vasculitis (CV) are the most frequent extrahepatic manifestations in chronically infected hepatitis C virus (HCV) patients. Antiviral therapy with interferon and ribavirin used to play an important rol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::258091f8b02cbb17af801dc4a0cb2834
https://doi.org/10.18821/0023-2149-2018-96-9-820-825

Zobrazit plný text záznamu

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)

Publikováno v: Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 41-51 (2018)

Aim of investigation. To estimate efficacy and safety of narlaprevir (NVR) with ritonavir (RTV), pegilated interferon (peg-IFN) and ribavirin (RBV) at treatmentnaïve and earlier treated noncirrhotic patients with chronic hepatitis C caused by the 1s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::288589d2bb6d4b70bfb0b1a3f2359722
https://www.gastro-j.ru/jour/article/view/191

Zobrazit plný text záznamu

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program

Autor: V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina

Publikováno v: Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 52-62 (2018)

Introduction. The options of antiviral therapy (AVT) in the stages of severe liver fibrosis and cirrhosis (LC) as well as in the patients with comorbidities for the long time were limited to the standard therapy by pegilated interferon (peg-IFN) in c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::3c3ebfea9356e0ef577fefca1cd2f85a
https://www.gastro-j.ru/jour/article/view/192

Zobrazit plný text záznamu

Persistent mixed cryoglobulinemia after successful antiviral treatment of chronic hepatitis C virus infection: What's the next?

Autor: D.T. Abdurakhmanov, M. L. Zubkin, O. I. Sagalova, Igor G. Bakulin, Vladimir Ivashkin, M. V. Maevskaya

Publikováno v: Scandinavian journal of gastroenterology. 53(7)

Mixed cryoglobulinemia (MC) and cryoglobulinemic vasculitis (CV) are the most common extrahepatic manifestations of chronic hepatitis C virus (HCV) infection. With novel interferon-free regimens ba...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0198968f4b98698c8c5301a4988843c6
https://pubmed.ncbi.nlm.nih.gov/29966445

Zobrazit plný text záznamu

Chronic hepatitis C in Russia: current challenges and prospects

Autor: Vladimir Chulanov, I V Shestakova, O. I. Sagalova, V. I. Pokrovsky, N.A. Mamonova, N. N. Pimenov

Publikováno v: Терапевтический архив, Vol 87, Iss 11, Pp 5-10 (2015)

This paper evaluates the impact of different medical care strategies for chronic hepatitis C patients in relation to its prevalence, frequency of adverse outcomes and mortality rate.Представлена оценка влияния различн�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cfc5840c1d7579395b6f4e89347563d
https://ter-arkhiv.ru/0040-3660/article/view/31835

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání